Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: A multicentre, double-blind, randomised placebo-controlled trial

The Lancet Global Health

Volumn 4, Issue 7, 2016, Pages e464-e473

  Berkley, James A ^a,b   Ngari, Moses ^a   Thitiri, Johnstone ^a   Mwalekwa, Laura ^a   Timbwa, Molline ^a   Hamid, Fauzat ^a   Ali, Rehema ^a   Shangala, Jimmy ^a   Mturi, Neema ^a   Jones, Kelsey D J ^a,d   Alphan, Hassan ^a   Mutai, Beatrice ^e   Bandika, Victor ^f   Hemed, Twahir ^f   Awuondo, Ken ^a   Morpeth, Susan ^a,c   Kariuki, Samuel ^g   Fegan, Gregory ^a,b  

^a KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e Mbagathi District Hospital   (Kenya)

^f Coast General Hospital ^*  (Kenya)

^g KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; COTRIMOXAZOLE; GENTAMICIN; PENICILLIN G; PLACEBO; ANTIINFECTIVE AGENT;

ANEMIA; ARTICLE; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; EPIDERMOLYSIS; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFANT; INFECTION; KWASHIORKOR; MAJOR CLINICAL STUDY; MALARIA; MALE; MALNUTRITION; MULTICENTER STUDY; NEUTROPENIA; PATIENT COMPLIANCE; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOFT TISSUE INFECTION; SURVIVAL; URINARY TRACT INFECTION; URTICARIA; CLINICAL TRIAL; KENYA; MORTALITY; PRESCHOOL CHILD; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; KENYA; MALE; SEVERE ACUTE MALNUTRITION; TREATMENT OUTCOME; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION;

EID: 84971645652     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(16)30096-1     Document Type: Article

References (35)

1. Bhutta ZA, Das JK, Rizvi A, et al. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?. Lancet 2013, 382:452-477.
2. Trehan I, Maleta KM, Manary MJ Antibiotics for uncomplicated severe malnutrition. N Engl J Med 2013, 368:2436-2437.
3. Isanaka S, Langendorf C, Berthe F, et al. Routine amoxicillin for uncomplicated severe acute malnutrition in children. N Engl J Med 2016, 374:444-453.
4. Guideline: updates on the management of severe acute malnutrition in infants and children 2013, WHO, World Health Organization, Geneva.
5. Pocket book for hospital care of children: guidelines for the management of common illness with limited resources WHO, (accessed March 9, 2015). http://www.who.int/maternal_child_adolescent/documents/9241546700/en/.
6. Bachou H, Tumwine JK, Mwadime RK, Ahmed T, Tylleskar T Reduction of unnecessary transfusion and intravenous fluids in severely malnourished children is not enough to reduce mortality. Ann Trop Paediatr 2008, 28:23-33.
7. Brewster DR Inpatient management of severe malnutrition: time for a change in protocol and practice. Ann Trop Paediatr 2011, 31:97-107.
8. Kerac M, Bunn J, Chagaluka G, et al. Follow-up of post-discharge growth and mortality after treatment for severe acute malnutrition (FuSAM study): a prospective cohort study. PLoS One 2014, 9:e96030.
9. Chisti MJ, Graham SM, Duke T, et al. Post-discharge mortality in children with severe malnutrition and pneumonia in Bangladesh. PLoS One 2014, 9:e107663.
10. Wiens MO, Pawluk S, Kissoon N, et al. Pediatric post-discharge mortality in resource poor countries: a systematic review. PLoS One 2013, 8:e66698.
11. Moisi JC, Gatakaa H, Berkley JA, et al. Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis. Bull World Health Organ 2011, 89:725-732. 732A.
12. Chintu C, Bhat GJ, Walker AS, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet 2004, 364:1865-1871.
13. Bwakura-Dangarembizi M, Kendall L, Bakeera-Kitaka S, et al. A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa. N Engl J Med 2014, 370:41-53.
14. Church JA, Fitzgerald F, Walker AS, Gibb DM, Prendergast AJ The expanding role of co-trimoxazole in developing countries. Lancet Infect Dis 2015, 15:327-339.
15. Craig JC, Simpson JM, Williams GJ, et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 2009, 361:1748-1759.
16. Garly ML, Bale C, Martins CL, et al. Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. BMJ 2006, 333:1245.
17. Aguilar C, Malphettes M, Donadieu J, et al. Prevention of infections during primary immunodeficiency. Clin Infect Dis 2014, 59:1462-1470.
18. Gough EK, Moodie EE, Prendergast AJ, et al. The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials. BMJ 2014, 348:g2267.
19. Bhutta ZA Antibiotics to promote growth in children?. BMJ 2014, 348:g2624.
20. Guidelines of co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults WHO, (accessed April 21, 2015). http://www.who.int/hiv/pub/guidelines/ctxguidelines.pdf.
21. Kenya Demographic and Health Survey Kenya National Bureau of Statistics, (accessed March 20, 2016). https://dhsprogram.com/pubs/pdf/FR308/FR308.pdf.
22. Dow A, Kayira D, Hudgens M, et al. Effects of cotrimoxazole prophylactic treatment on adverse health outcomes among HIV-exposed, uninfected infants. Pediatr Infect Dis J 2012, 31:842-847.
23. Sandison TG, Homsy J, Arinaitwe E, et al. Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial. BMJ 2011, 342:d1617.
24. Mbeye NM, Ter Kuile FO, Davies MA, et al. Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health 2014, 19:1057-1067.
25. Coutsoudis A, Kindra G, Esterhuizen T Impact of cotrimoxazole prophylaxis on the health of breast-fed, HIV-exposed, HIV-negative infants in a resource-limited setting. AIDS 2011, 25:1797-1799.
26. Brent AJ, Ahmed I, Ndiritu M, et al. Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study. Lancet 2006, 367:482-488.
27. Rudan I, O'Brien KL, Nair H, et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health 2013, 3:010401.
28. D'Acremont V, Kilowoko M, Kyungu E, et al. Beyond malaria-causes of fever in outpatient Tanzanian children. N Engl J Med 2014, 370:809-817.
29. Berkley JA, Munywoki P, Ngama M, et al. Viral etiology of severe pneumonia among Kenyan infants and children. JAMA 2010, 303:2051-2057.
30. Porco TC, Gebre T, Ayele B, et al. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA 2009, 302:962-968.
31. Coles CL, Levens J, Seidman JC, Mkocha H, Munoz B, West S Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children. Pediatr Infect Dis J 2012, 31:341-346.
32. Gilliams EA, Jumare J, Claassen CW, et al. Chloroquine-azithromycin combination antimalarial treatment decreases risk of respiratory- and gastrointestinal-tract infections in Malawian children. J Infect Dis 2014, 210:585-592.
33. Taylor WR, Richie TL, Fryauff DJ, et al. Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clin Infect Dis 1999, 28:74-81.
34. Korpe PS, Petri WA Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med 2012, 18:328-336.
35. Kerac M, Blencowe H, Grijalva-Eternod C, et al. Prevalence of wasting among under 6-month-old infants in developing countries and implications of new case definitions using WHO growth standards: a secondary data analysis. Arch Dis Child 2011, 96:1008-1013.